Literature DB >> 28504072

'Pragmatic' and 'explanatory' attitudes to randomised trials.

Merrick Zwarenstein1.   

Abstract

Mesh：

Year:  2017        PMID： 28504072      PMCID： PMC5438067          DOI： 10.1177/0141076817706303

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  14 in total

1.  The clinical trial.

Authors:  A B HILL
Journal:  Br Med Bull       Date:  1951       Impact factor: 4.291

2.  A pragmatic-explanatory continuum indicator summary (PRECIS): a tool to help trial designers.

Authors:  Kevin E Thorpe; Merrick Zwarenstein; Andrew D Oxman; Shaun Treweek; Curt D Furberg; Douglas G Altman; Sean Tunis; Eduardo Bergel; Ian Harvey; David J Magid; Kalipso Chalkidou
Journal:  J Clin Epidemiol       Date:  2009-05       Impact factor: 6.437

3.  STREPTOMYCIN treatment of pulmonary tuberculosis.

Authors: 
Journal:  Br Med J       Date:  1948-10-30

4.  The clinical trial.

Authors:  A B HILL
Journal:  N Engl J Med       Date:  1952-07-24       Impact factor: 91.245

5.  UK Medical Research Council and multicentre clinical trials: from a damning report to international recognition.

Authors:  Iain Chalmers
Journal:  J R Soc Med       Date:  2013-12       Impact factor: 5.344

6.  Exploring the pragmatic and explanatory study design on outcomes of systematic reviews of public health interventions: a case study on obesity prevention trials.

Authors:  Sze Lin Yoong; Luke Wolfenden; Tara Clinton-McHarg; Elizabeth Waters; Tahna L Pettman; Emily Steele; John Wiggers
Journal:  J Public Health (Oxf)       Date:  2014-03       Impact factor: 2.341

7.  The FDA's critique of the anturane reinfarction trial.

Authors:  R Temple; G W Pledger
Journal:  N Engl J Med       Date:  1980-12-18       Impact factor: 91.245

8.  Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI).

Authors: 
Journal:  Lancet       Date:  1986-02-22       Impact factor: 79.321

9.  A prospective trial of intravenous streptokinase in acute myocardial infarction (I.S.A.M.). Mortality, morbidity, and infarct size at 21 days.

Authors: 
Journal:  N Engl J Med       Date:  1986-06-05       Impact factor: 91.245

10.  Mesmer's 1780 proposal for a controlled trial to test his method of treatment using "animal magnetism".

Authors:  I M L Donaldson
Journal:  J R Soc Med       Date:  2005-12       Impact factor: 18.000
View more
  7 in total

1.  Methodological challenges in pragmatic trials in Alzheimer's disease and related dementias: Opportunities for improvement.

Authors:  Monica Taljaard; Fan Li; Bo Qin; Caroline Cui; Leyi Zhang; Stuart G Nicholls; Kelly Carroll; Susan L Mitchell
Journal:  Clin Trials       Date:  2021-11-29       Impact factor: 2.486

2.  Research and Scholarly Methods: Pragmatic Clinical Trials.

Authors:  Onyeche Oche; Chaorong Wu; Logan T Murry; Korey A Kennelty
Journal:  J Am Coll Clin Pharm       Date:  2021-11-02

Review 3.  Clinical drug trials in general practice: how well are external validity issues reported?

Authors:  Anja Maria Brænd; Jørund Straand; Atle Klovning
Journal:  BMC Fam Pract       Date:  2017-12-29       Impact factor: 2.497

4.  Developing a framework for the ethical design and conduct of pragmatic trials in healthcare: a mixed methods research protocol.

Authors:  Monica Taljaard; Charles Weijer; Jeremy M Grimshaw; Adnan Ali; Jamie C Brehaut; Marion K Campbell; Kelly Carroll; Sarah Edwards; Sandra Eldridge; Christopher B Forrest; Bruno Giraudeau; Cory E Goldstein; Ian D Graham; Karla Hemming; Spencer Phillips Hey; Austin R Horn; Vipul Jairath; Terry P Klassen; Alex John London; Susan Marlin; John C Marshall; Lauralyn McIntyre; Joanne E McKenzie; Stuart G Nicholls; P Alison Paprica; Merrick Zwarenstein; Dean A Fergusson
Journal:  Trials       Date:  2018-09-27       Impact factor: 2.279

5.  Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review.

Authors:  Chiara Gastaldon; Franziska Mosler; Sarah Toner; Federico Tedeschi; Victoria Jane Bird; Corrado Barbui; Stefan Priebe
Journal:  PLoS One       Date:  2019-09-24       Impact factor: 3.240

6.  Building internal capacity in pragmatic trials: a workshop for program scientists at the US National Cancer Institute.

Authors:  Wynne E Norton; Merrick Zwarenstein; Susan Czajkowski; Elisabeth Kato; Ann O'Mara; Nonniekaye Shelburne; David A Chambers; Kirsty Loudon
Journal:  Trials       Date:  2019-12-27       Impact factor: 2.279

Review 7.  [Benefit assessment of digital health applications-challenges and opportunities].

Authors:  Lars G Hemkens
Journal:  Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz       Date:  2021-09-15       Impact factor: 1.513
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.